Global Carbapenem Antibiotics Competitive Landscape Professional Research Report 2024

Research Summary

Carbapenem antibiotics are a class of broad-spectrum antibiotics known for their potent activity against a wide range of bacterial infections. They belong to the beta-lactam family of antibiotics and are often considered as the ? 1/4 ?last-resort? 1/4 ? treatment option for severe bacterial infections that are resistant to other antibiotics. Carbapenems work by inhibiting the synthesis of bacterial cell walls, leading to the disruption of bacterial growth and ultimately causing their death. They are effective against both Gram-positive and Gram-negative bacteria, including multi-drug resistant strains. Due to their broad-spectrum activity and efficacy, carbapenems are commonly used in hospital settings for treating serious infections such as pneumonia, urinary tract infections, intra-abdominal infections, and bloodstream infections caused by various bacteria. However, due to the emergence of carbapenem-resistant organisms, the appropriate use and careful monitoring of carbapenem antibiotics are crucial to preserve their effectiveness.

According to DIResearch's in-depth investigation and research, the global Carbapenem Antibiotics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Carbapenem Antibiotics include ACS Dobfar, Iterum Therapeutics plc, DAEWOONG PHARMACEUTICAL, Aurobindo Pharma, Merck, Gland Pharma Limited, Sumitomo Dainippon Pharma, Savior Lifetec, Pfizer Inc., Spero Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Carbapenem Antibiotics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Carbapenem Antibiotics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Carbapenem Antibiotics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Carbapenem Antibiotics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Carbapenem Antibiotics Include:

ACS Dobfar

Iterum Therapeutics plc

DAEWOONG PHARMACEUTICAL

Aurobindo Pharma

Merck

Gland Pharma Limited

Sumitomo Dainippon Pharma

Savior Lifetec

Pfizer Inc.

Spero Therapeutics

Carbapenem Antibiotics Product Segment Include:

Meropenem

Donipenem

Imipenem

Tipipenem

Others

Carbapenem Antibiotics Product Application Include:

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Carbapenem Antibiotics Industry PESTEL Analysis

Chapter 3: Global Carbapenem Antibiotics Industry Porter's Five Forces Analysis

Chapter 4: Global Carbapenem Antibiotics Major Regional Market Size and Forecast Analysis

Chapter 5: Global Carbapenem Antibiotics Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Carbapenem Antibiotics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Carbapenem Antibiotics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Carbapenem Antibiotics Market Overview

1.1 Product Definition and Statistical Scope

1.2 Carbapenem Antibiotics Product by Type

1.2.1 Global Carbapenem Antibiotics Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Meropenem

1.2.3 Donipenem

1.2.4 Imipenem

1.2.5 Tipipenem

1.2.6 Others

1.3 Carbapenem Antibiotics Product by Application

1.3.1 Global Carbapenem Antibiotics Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Retail Pharmacy

1.3.3 Online Pharmacy

1.3.4 Hospital Pharmacy

1.4 Global Carbapenem Antibiotics Market Revenue Analysis (2019-2030)

1.5 Carbapenem Antibiotics Market Development Status and Trends

1.5.1 Carbapenem Antibiotics Industry Development Status Analysis

1.5.2 Carbapenem Antibiotics Industry Development Trends Analysis

2 Carbapenem Antibiotics Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Carbapenem Antibiotics Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Carbapenem Antibiotics Market Analysis by Regions

4.1 Carbapenem Antibiotics Overall Market: 2023 VS 2024 VS 2030

4.2 Global Carbapenem Antibiotics Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Carbapenem Antibiotics Revenue and Market Share by Region (2019-2024)

4.2.2 Global Carbapenem Antibiotics Revenue Forecast by Region (2025-2030)

5 Global Carbapenem Antibiotics Market Size by Type and Application

5.1 Global Carbapenem Antibiotics Market Size by Type

5.2 Global Carbapenem Antibiotics Market Size by Application

6 North America

6.1 North America Carbapenem Antibiotics Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Carbapenem Antibiotics Market Size by Type

6.4 North America Carbapenem Antibiotics Market Size by Application

6.5 North America Carbapenem Antibiotics Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Carbapenem Antibiotics Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Carbapenem Antibiotics Market Size by Type

7.4 Europe Carbapenem Antibiotics Market Size by Application

7.5 Europe Carbapenem Antibiotics Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Carbapenem Antibiotics Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Carbapenem Antibiotics Market Size by Type

8.4 China Carbapenem Antibiotics Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Carbapenem Antibiotics Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Carbapenem Antibiotics Market Size by Type

9.4 APAC (excl. China) Carbapenem Antibiotics Market Size by Application

9.5 APAC (excl. China) Carbapenem Antibiotics Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Carbapenem Antibiotics Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Carbapenem Antibiotics Market Size by Type

10.4 Latin America Carbapenem Antibiotics Market Size by Application

10.5 Latin America Carbapenem Antibiotics Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Carbapenem Antibiotics Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Carbapenem Antibiotics Market Size by Type

11.4 Middle East & Africa Carbapenem Antibiotics Market Size by Application

11.5 Middle East & Africa Carbapenem Antibiotics Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Carbapenem Antibiotics Market Revenue by Key Manufacturers (2020-2024)

12.2 Carbapenem Antibiotics Competitive Landscape Analysis and Market Dynamic

12.2.1 Carbapenem Antibiotics Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 ACS Dobfar

13.1.1 ACS Dobfar Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 ACS Dobfar Carbapenem Antibiotics Product Portfolio

13.1.3 ACS Dobfar Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Iterum Therapeutics plc

13.2.1 Iterum Therapeutics plc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Iterum Therapeutics plc Carbapenem Antibiotics Product Portfolio

13.2.3 Iterum Therapeutics plc Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 DAEWOONG PHARMACEUTICAL

13.3.1 DAEWOONG PHARMACEUTICAL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 DAEWOONG PHARMACEUTICAL Carbapenem Antibiotics Product Portfolio

13.3.3 DAEWOONG PHARMACEUTICAL Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Aurobindo Pharma

13.4.1 Aurobindo Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Aurobindo Pharma Carbapenem Antibiotics Product Portfolio

13.4.3 Aurobindo Pharma Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Merck

13.5.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Merck Carbapenem Antibiotics Product Portfolio

13.5.3 Merck Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Gland Pharma Limited

13.6.1 Gland Pharma Limited Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Gland Pharma Limited Carbapenem Antibiotics Product Portfolio

13.6.3 Gland Pharma Limited Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Sumitomo Dainippon Pharma

13.7.1 Sumitomo Dainippon Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Sumitomo Dainippon Pharma Carbapenem Antibiotics Product Portfolio

13.7.3 Sumitomo Dainippon Pharma Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Savior Lifetec

13.8.1 Savior Lifetec Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Savior Lifetec Carbapenem Antibiotics Product Portfolio

13.8.3 Savior Lifetec Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Pfizer Inc.

13.9.1 Pfizer Inc. Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Pfizer Inc. Carbapenem Antibiotics Product Portfolio

13.9.3 Pfizer Inc. Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Spero Therapeutics

13.10.1 Spero Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Spero Therapeutics Carbapenem Antibiotics Product Portfolio

13.10.3 Spero Therapeutics Carbapenem Antibiotics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Carbapenem Antibiotics Industry Chain Analysis

14.2 Carbapenem Antibiotics Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Carbapenem Antibiotics Typical Downstream Customers

14.4 Carbapenem Antibiotics Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support